108 related articles for article (PubMed ID: 10574191)
1. Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching.
Zhong L; Yeh KC
J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):63-71. PubMed ID: 10574191
[TBL] [Abstract][Full Text] [Related]
2. Simple and sensitive high-performance liquid chromatography method for the quantitation of indinavir in rat plasma and central nervous system.
Hamidi M
J Sep Sci; 2006 Mar; 29(5):620-7. PubMed ID: 16605079
[TBL] [Abstract][Full Text] [Related]
3. Determination of indinavir in plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 1999 Aug; 21(4):404-10. PubMed ID: 10442693
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy.
Langmann P; Klinker H; Schirmer D; Zilly M; Bienert A; Richter E
J Chromatogr B Biomed Sci Appl; 1999 Nov; 735(1):41-50. PubMed ID: 10630889
[TBL] [Abstract][Full Text] [Related]
5. Determination of famotidine in human plasma by high performance liquid chromatography with column switching.
Zhong L; Yeh KC
J Pharm Biomed Anal; 1998 Feb; 16(6):1051-7. PubMed ID: 9547709
[TBL] [Abstract][Full Text] [Related]
6. [Simultaneous quantitative determination of amprenavir and indinavir in human plasma by high-performance liquid chromatography].
Laussine S; Roux A; Delhotal-Landes B; Flouvat B
Ann Biol Clin (Paris); 2001; 59(2):169-75. PubMed ID: 11282520
[TBL] [Abstract][Full Text] [Related]
7. Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography.
Burger DM; de Graaff M; Wuis EW; Koopmans PP; Hekster YA
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):235-41. PubMed ID: 9448081
[TBL] [Abstract][Full Text] [Related]
8. Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.
Letendre SL; Capparelli EV; Ellis RJ; McCutchan JA
Antimicrob Agents Chemother; 2000 Aug; 44(8):2173-5. PubMed ID: 10898694
[TBL] [Abstract][Full Text] [Related]
9. Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography.
Li W; Coombs RW; Collier AC; Raisys VA
Ther Drug Monit; 1999 Jun; 21(3):360-6. PubMed ID: 10365654
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
[TBL] [Abstract][Full Text] [Related]
11. Determination of an in vivo metabolite of a human immunodeficiency virus protease-inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
Woolf E; Haddix HM; Matuszewski B
J Chromatogr A; 1997 Feb; 762(1-2):311-9. PubMed ID: 9098990
[TBL] [Abstract][Full Text] [Related]
12. Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching.
Woolf E; Au T; Haddix H; Matuszewski B
J Chromatogr A; 1995 Feb; 692(1-2):45-52. PubMed ID: 7719460
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of unlabeled and deuterium-labeled indinavir in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
Woolf EJ; Matuszewski BK
J Pharm Sci; 1997 Feb; 86(2):193-8. PubMed ID: 9040094
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of indinavir, ritonavir and lopinavir (ABT 378) in human plasma by high-performance liquid chromatography.
Ray J; Pang E; Carey D
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):225-30. PubMed ID: 12113989
[TBL] [Abstract][Full Text] [Related]
16. Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma.
Jayewardene AL; Zhu F; Aweeka FT; Gambertoglio JG
J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):203-11. PubMed ID: 9613951
[TBL] [Abstract][Full Text] [Related]
17. High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC-MS/MS.
Rose MJ; Merschman SA; Eisenhandler R; Woolf EJ; Yeh KC; Lin L; Fang W; Hsieh J; Braun MP; Gatto GJ; Matuszewski BK
J Pharm Biomed Anal; 2000 Dec; 24(2):291-305. PubMed ID: 11130208
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir in human plasma by UPLC-ESI-MS-MS.
Das Mishra T; Kurani H; Singhal P; Shrivastav PS
J Chromatogr Sci; 2012 Aug; 50(7):625-35. PubMed ID: 22562821
[TBL] [Abstract][Full Text] [Related]
19. An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma.
Jayewardene AL; Kearney B; Stone JA; Gambertoglio JG; Aweeka FT
J Pharm Biomed Anal; 2001 May; 25(2):309-17. PubMed ID: 11275438
[TBL] [Abstract][Full Text] [Related]
20. Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system.
Martin C; Sönnerborg A; Svensson JO; Ståhle L
AIDS; 1999 Jul; 13(10):1227-32. PubMed ID: 10416527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
